Insider Shareholders with Direct Ownership of Invo Bioscience, Inc. (INVO)
This section provides a comprehensive overview of the insiders with direct ownership of Invo Bioscience, Inc. (INVO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
INVO Bioscience, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Steve Shum
Chief Executive Officer |
109,670 | 0 | 128,420 $102,736 | 3 |
Jun 01, 2022
Added 31.44%
|
|
Michael Jos. Campbell
Chief Operating Officer |
25,762 | 0 | 75,762 $60,609 | 2 |
Jun 01, 2022
Added 12.2%
|
|
Matthew K Szot
Director |
39,175 | 0 | 39,175 $31,340 | 4 |
Jun 01, 2022
Added 26.98%
|
|
Trent D Davis
Director |
30,524 | 0 | 33,622 $26,897 | 3 |
Jun 01, 2022
Added 24.96%
|
|
Jeffrey Segal
Director |
27,220 | 0 | 28,220 $22,576 | 4 |
Jun 01, 2022
Added 24.61%
|
|
Rebecca Messina
Director |
22,985 | 0 | 23,045 $18,436 | 3 |
Jun 01, 2022
Added 29.98%
|
|
Barbara Ryan
Director |
31,579 | 0 | 22,991 $18,392 | 4 |
Jun 01, 2022
Added 31.4%
|
|
Andrea Goren
Chief Financial Officer |
5,361 | 0 | 17,861 $14,288 | 1 |
Jan 15, 2022
Added 23.09%
|
|
Kevin Doody
Medical Director |
15,664 | 177,306 | 0 $0 | 3 |
Jun 01, 2022
Reduced 100.0%
|